Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort
Open accessThe DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Abstract
Epilepsy is common in early childhood. In this age group it is associated with high rates of therapy-resistance, and with cognitive, motor, and behavioural comorbidity. A large number of genes, with wide ranging functions, are implicated in its aetiology, especially in those with therapy-resistant seizures. Identifying the more common single-gene epilepsies will aid in targeting resources, the prioritization of diagnostic testing and development of precision therapy. Previous studies of genetic testing in epilepsy have not been prospective and population-based. Therefore, the population-incidence of common genetic epilepsies remains unknown. The objective of this study was to describe the incidence and phenotypic spectrum of the most common single-gene epilepsies in young children, and to calculate what proportion are amenable to precision therapy. This was a prospective national epidemiological cohort study. All children presenting with epilepsy before 36 months of age were eligible. Children presenting with recurrent prolonged (>10 min) febrile seizures; febrile or afebrile status epilepticus (>30 min); or with clusters of two or more febrile or afebrile seizures within a 24-h period were also eligible. Participants were recruited from all 20 regional paediatric departments and four tertiary children’s hospitals in Scotland over a 3-year period. DNA samples were tested on a custom-designed 104-gene epilepsy panel. Detailed clinical information was systematically gathered at initial presentation and during follow-up. Clinical and genetic data were reviewed by a multidisciplinary team of clinicians and genetic scientists. The pathogenic significance of the genetic variants was assessed in accordance with the guidelines of UK Association of Clinical Genetic Science (ACGS). Of the 343 patients who met inclusion criteria, 333 completed genetic testing, and 80/333 (24%) had a diagnostic genetic finding. The overall estimated annual incidence of single-gene epilepsies in this well-defined population was 1 per 2120 live births (47.2/100 000; 95% confidence interval 36.9–57.5). PRRT2 was the most common single-gene epilepsy with an incidence of 1 per 9970 live births (10.0/100 000; 95% confidence interval 5.26–14.8) followed by SCN1A: 1 per 12 200 (8.26/100 000; 95% confidence interval 3.93–12.6); KCNQ2: 1 per 17 000 (5.89/100 000; 95% confidence interval 2.24–9.56) and SLC2A1: 1 per 24 300 (4.13/100 000; 95% confidence interval 1.07–7.19). Presentation before the age of 6 months, and presentation with afebrile focal seizures were significantly associated with genetic diagnosis. Single-gene disorders accounted for a quarter of the seizure disorders in this cohort. Genetic testing is recommended to identify children who may benefit from precision treatment and should be mainstream practice in early childhood onset epilepsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Loss-of-function (LOF) missense or truncating variants cause Dravet syndrome, the prototypic DEE 13,27 , and also the non-DEE syndrome of Genetic Epilepsy with Febrile Seizures Plus (GEFS+) 28 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The incidence of syndromes associated with de novo genetic variants is likely to be similar around the world 13 ; whereas, recessive causes occur more frequently in populations with high rates of consanguinity 14 .”
From Developmental and epileptic encephalopathies (2024) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
Early Identification of Refractory Epilepsy
Kwan, P., & Brodie, M. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002033420503 · Cited by 5,204
Scheffer, I. E., Berkovic, S., Capovilla, G., Connolly, M. B., French, J., Guilhoto, L., Hirsch, E., Jain, S., Mathern, G. W., Moshé, S. L., et al. (2017) · Epilepsia · doi:10.1111/epi.13709 · Cited by 5,054 · cited 1×
“The concept of the ‘developmental and epileptic encephalopathy’ (DEE) recognizes that in children presenting with early-onset epilepsy, neurodevelopmental comorbidity may be attributable to both the underlying cause and to the detrimental effects of uncontrolled epileptic activity (Scheffer et al., 2017).”
Self-citationIncidence of Epilepsy and Unprovoked Seizures in Rochester, Minnesota: 1935–1984
Hauser, W. A., Annegers, J. F., & Kurland, L. T. (1993) · Epilepsia · doi:10.1111/j.1528-1157.1993.tb02586.x · Cited by 2,073
Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies
Fiest, K. M., Sauro, K. M., Wiebe, S., Patten, S. B., Kwon, C.-S., Dykeman, J., Pringsheim, T., Lorenzetti, D. L., & Jetté, N. (2017) · Neurology · doi:10.1212/wnl.0000000000003509 · Cited by 1,902
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., Scheffer, I. E., Thiele, E. A., & Wright, S. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1611618 · Cited by 1,711
Estimation of the burden of active and life-time epilepsy: a meta-analytic approach
Ngugi, A. K., Bottomley, C., Kleinschmidt, I., Sander, J. W., & Newton, C. R. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2009.02481.x · Cited by 1,447 · cited 1×
“, 2017) and that 50–65 million individuals are affected worldwide (Ngugi et al., 2010; Fiest et al., 2017).”
A Potassium Channel Mutation in Neonatal Human Epilepsy
Biervert, C., Schroeder, B. C., Kubisch, C., Berkovic, S. F., Propping, P., Jentsch, T. J., & Steinlein, O. K. (1998) · Science · doi:10.1126/science.279.5349.403 · Cited by 1,073 · cited 1×
“The literature describes two distinct phenotypes associated with KCNQ2 variants: a self-limited familial neonatal seizure phenotype (Biervert et al., 1998; Singh et al., 2003) and a severe neonatal-onset developmental and epileptic encephalopathy (Weckhuysen et al.”
Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome
Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., Greenwood, S. M., Roberts, C., Checketts, D., VanLandingham, K. E., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714631 · Cited by 1,015 · cited 2×
“Cannabidiol also has efficacy in Lennox Gastaut syndrome (French et al., 2017; Devinsky et al., 2018), an epilepsy with varied aetiologies.”
Self-citationDevinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras‐Aswad, D., Notcutt, W. G., et al. (2014) · Epilepsia · doi:10.1111/epi.12631 · Cited by 1,000 · cited 1×
“In Dravet syndrome cannabidiol demonstrates efficacy (Devinsky et al. , 2017); however, there is no biological reason why cannabidiol should be specifically effective in this condition because it does not appear to act on sodium channels or GABA receptors (Devinsky et al. , 2014).”
Research works printed but not linked: 1
- The Broad Institute: Cambridge MA 2018. gnomAD Browser. http://gnomad.broadinstitute.org/(April 2018, date last accessed).
Cited by
Items 201–300 of 456
Voltage-Gated Ion Channel Compensatory Effect in DEE: Implications for Future Therapies
Shabani, K., Krupp, J., Lemesre, E., Lévy, N., & Tran, H. (2024) · Cells · doi:10.3390/cells13211763 · Cited by 8
Genotype‐function‐phenotype correlations for SCN1A variants identified by clinical genetic testing
Knox, A. T., Thompson, C. H., Scott, D., Abramova, T. V., Stieve, B. J., Freeman, A., & George, A. L. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.52297 · Cited by 9
Stimuli-responsive nanoscale drug delivery system for epilepsy theranostics
Zhang, Q., Wang, Y., Wu, D., & Chen, Z. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.01.046 · Cited by 11
Mortality in children with epilepsy: Cohort study using the clinical practice research datalink
Schnier, C., & Chin, R. (2023) · Seizure · doi:10.1016/j.seizure.2023.05.020 · Cited by 7
Genetic Testing in Pediatric Epilepsy: Tools, Tips, and Navigating the Traps
Chowdhury, S. R., Whitney, R., RamachandranNair, R., Mahay, S. B., & Sharma, S. (2024) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2024.05.008 · Cited by 7
Murthy, M. C., Banerjee, B., Shetty, M., Mariappan, M., & Sekhsaria, A. (2024) · Epileptic Disorders · doi:10.1002/epd2.20254 · Cited by 8
Gokce‐Samar, Z., de Bellescize, J., Arzimanoglou, A. A., Putoux, A., Chatron, N., Lesca, G., & Portes, V. D. (2022) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2022.104636 · Cited by 8
Lenge, M., Balestrini, S., Napolitano, A., Mei, D., Conti, V., Baldassari, G., Trivisano, M., Pellacani, S., Macconi, L., Longo, D., et al. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02753-x · Cited by 10
Jones, L., Peters, C. H., Rosch, R. E., Owers, M., Hughes, E., Pal, D. K., & Ruben, P. C. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.788192 · Cited by 8
Shen, F., Lu, L., Youjia, W., Suo, G., Zheng, Y., Zhong, X., Wang, X., & Li, H. (2024) · BMC Pediatrics · doi:10.1186/s12887-024-04895-9 · Cited by 6
Vineland-3 Growth Scale Values: Psychometric Properties for Clinical Trial Readiness in SCN2A
Kaat, A. J., Evans, L. M., Nili, A. N., Paltell, K. C., Kaiser, A., Anderson, E. L., Myers, L. S., & Berg, A. T. (2025) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2024.0107 · Cited by 11
Bavdhankar, K., & Agarwal, P. A. (2025) · Annals of Movement Disorders · doi:10.4103/aomd.aomd_115_24 · Cited by 6
Monogenic Epilepsies in Adult Epilepsy Clinics and Gene-Driven Approaches to Treatment
Clayton, L. M. S., Vakrinou, A., Balestrini, S., & Sisodiya, S. M. (2025) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-025-01413-x · Cited by 8
Dressler, A., Bonfanti, L., Trimmel‐Schwahofer, P., Porsche, B., Bertoli, S., & Male, C. (2025) · Nutrients · doi:10.3390/nu17132085 · Cited by 6
Barriers to the implementation of epilepsy genetic testing and counseling guidelines
Melly, S., Bergner, A. L., Sands, T. T., Lippa, N. C., & Mulhern, M. (2025) · Epilepsia Open · doi:10.1002/epi4.70125 · Cited by 6
McTague, A., Scheffer, I. E., Kullmann, D. M., & Sisodiya, S. M. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90820-7.00016-1 · Cited by 8
Trauma, coping, and adjustment when parenting a child with Dravet syndrome
Mercier, A., Dorris, L., Brunklaus, A., Symonds, J. D., Zuberi, S. M., Finch, T., Wilson, G., & Eldred, C. (2025) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2025.01.002 · Cited by 9
Self-citationRelationship Between Epileptic Activity and Developmental Outcome in KCNQ2-Related Epilepsy
Casas‐Alba, D., Aguilar, A., Alonso, I., García, M. T., Cilio, M. R., Fons, C., Pisón, J. L., Gutiérrez-Solana, L., Ferragut, F., Ruiz-Falcó, M. L., et al. (2023) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2023.03.004 · Cited by 6
Clinical and genetic analysis of benign familial infantile epilepsy caused by PRRT2 gene variant
Gu, Y., Mei, D., Wang, X., Ma, A., Kong, J., & Zhang, Y. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1135044 · Cited by 6
Zhang, Y., Xue, Y., Ma, Y., Du, X., Lu, B., Wang, Y., & Yan, Z. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122378 · Cited by 9
Li, X., Gao, Z., Ma, M., Li, L., & Guo, S. (2021) · Journal of Medical Biochemistry · doi:10.5937/jomb0-32988 · Cited by 6
Movement Disorders and Inherited Metabolic Disorders: Recognition, Understanding, Improving Outcomes
(2020) · Cambridge University Press eBooks · doi:10.1017/9781108556767 · Cited by 10
Lewis‐Smith, D., & Thomas, R. H. (2020) · Epilepsia · doi:10.1111/epi.16640 · Cited by 6
Management of Developmental and Epileptic Encephalopathies
Vasquez, A., & Fine, A. L. (2025) · Seminars in Neurology · doi:10.1055/a-2534-3267 · Cited by 7
Zhang, M.-J., Zhang, S.-M., Zhang, Q., Wen, Y., Wang, J.-P., Jiang, Y.-W., & Bao, X. (2025) · World Journal of Pediatrics · doi:10.1007/s12519-025-00884-9 · Cited by 5
Özcan, M., Kanmaz, S., Şimşek, E., Toprak, D. E., Ölçülü, C. B., İnce, T., Yılmaz, Ö., Ataş, Y., Şen, G., Aykut, A., et al. (2025) · Epileptic Disorders · doi:10.1002/epd2.70012 · Cited by 6
Genome‐Wide Insights and Polygenic Risk Scores in Common Epilepsies: A Narrative Review
Mastrangelo, M., Petrucci, S., Lentini, G., Fabiani, M., Piane, M., & Pisani, F. (2025) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.33040 · Cited by 6
Andersson, K., Bjurulf, B., Dellenmark‐Blom, M., Hallböök, T., Esserlind, A.-L., & Reilly, C. J. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110750 · Cited by 5
Ochoa‐Urrea, M., Butler, E., Brünger, T., Leu, C., Boßelmann, C. M., Najm, I., Lhatoo, S. D., & Lal, D. (2025) · Neurology · doi:10.1212/wnl.0000000000214235 · Cited by 10
Balestrini, S., & Scheffer, I. E. (2026) · CNS Drugs · doi:10.1007/s40263-026-01276-x · Cited by 11
Saldaris, J. M., Jacoby, P. A., Downs, J. A., Marsh, E. D., Leonard, H., Pestana‐Knight, E., Rajaraman, R. R., Weisenberg, J. L. Z., Suter, B., Olson, H. E., et al. (2024) · Epilepsia · doi:10.1111/epi.18094 · Cited by 5
Exploring neurodevelopment in CDKL5 deficiency disorder: Current insights and future directions
Dell’Isola, G. B., Perinelli, M. G., Frulli, A., D’Onofrio, G., Fattorusso, A., Siciliano, M., Ferrara, P., Striano, P., & Verrotti, A. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110504 · Cited by 6
Martinez, D., Jiang, E., & Zhou, Z. (2024) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-024-09517-0 · Cited by 9
Donnellan, E. P., Kehoe, C. M., Moran, A., Chollatain, M. N., Hynes, Y., Hennessy, M. J., Reade, E., & Allen, N. M. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.109804 · Cited by 5
Saldaris, J. M., Demarest, S., Jacoby, P., Olson, H., Maski, K., Pestana-Knight, E., Price, D., Rajaraman, R., Suter, B., Weisenberg, J., et al. (2024) · Journal of Clinical Sleep Medicine (JCSM) · doi:10.5664/jcsm.11244 · Cited by 5
Nguyen, Y. T. M., Vu, B.-Q., Nguyen, D.-K., Quach, N.-V., Bui, L. T., Hong, J., & Bui, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-72683-7 · Cited by 5
Plural molecular and cellular mechanisms of pore domain KCNQ2 encephalopathy
Abreo, T. J., Thompson, E. C., Madabushi, A., Soh, H., Varghese, N., Vanoye, C. G., Springer, K., Springer, K., Johnson, J., Sims, S., et al. (2025) · eLife · doi:10.7554/elife.91204.3 · Cited by 12
Loi, M., Valenti, F., Trazzi, S., Mottolese, N., Candini, G., Bove, A. M., Trebbi, F., Pincigher, L., Fato, R., Bergamini, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052204 · Cited by 8
Dai, K., Tang, D., Bao, L., Li, S., Chen, N., Ye, W., Song, A., Liao, S., & Li, T. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103154 · Cited by 6
Incidence of Aicardi-Goutières syndrome and KCNT1-related epilepsy in Denmark
Møller, R. S., Zhao, L., Shoaff, J. R., Dunø, M., Andersen, B. N., Nguyen, V., Fang, T., Kupelian, V. A., & Thorén, R. (2022) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2022.100924 · Cited by 11
Deficiency of cyclin-dependent kinase-like 5 causes spontaneous epileptic seizures in neonatal micePreprint
Liao, W., Lee, K.-Z., Su, S.-H., & Luo, Y. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.09.983981 · Cited by 4
Li, Y., Dai, S., Deng, Q., & Liu, Z. (2025) · Seizure · doi:10.1016/j.seizure.2025.05.001 · Cited by 6
Genetic modifiers of epilepsy: A narrative review
Rizvi, S., Raza, S. T., & Mahdi, F. (2025) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2025.104038 · Cited by 4
Keeley, J., Skoda, Z., Utley, K., Marsh, E. D., Conecker, G., Hecker, J., Ludwig, N. N., Leonard, H., Saldaris, J. M., Jacoby, P. A., et al. (2025) · Quality of Life Research · doi:10.1007/s11136-025-04048-0 · Cited by 6
Saranti, A., Dragoumi, P., Pavlogiannis, K., Pavlou, E., & Zafeiriou, D. (2025) · Seizure · doi:10.1016/j.seizure.2025.10.001 · Cited by 6
Heineman, K. R., Hielkema, T., Teunissen, M. W. A., & van den Berg, L. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106441 · Cited by 4
Yalçın, G., Yıldırım, R., Ünal, E., Cebeci, D., Ersen, A., Özyılmaz, B., Tekeş, S., Anıl, M., & Gürbay, A. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14227918 · Cited by 6
Salcedo‐Pérez‐Juana, M., Florêncio, L. L., San-Martín-Gómez, A., Pérez‐Corrales, J., García‐Bravo, C., Aledo‐Serrano, Á., & Palacios‐Ceña, D. (2025) · Child Care Health and Development · doi:10.1111/cch.70215 · Cited by 4
Gallo, N. B., Annand, J. W., Clarner, P., Harvey, B., Morozova, E., Ehrenfels, C., Jiang, T., Yuan, L., Kashyap, S., Lü, X., et al. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.03.027 · Cited by 5
Mastrangelo, M., Manti, F., Ricciardi, G., Bove, R., Greco, C., Tolve, M., & Pisani, F. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.109670 · Cited by 4
Wang, J., Wang, Y., Hu, L., Shi, X., He, W., Sun, D., Li, B., Liu, X., Xu, S., Du, L., et al. (2025) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70114 · Cited by 7
Ngo, T. T. D., Lea, R. A., Maksemous, N., Eccles, D., Smith, R. A., Dunn, P. J., Cao, T. V., Hà, T. M. T., Bui, C., Haupt, L. M., et al. (2021) · Epilepsy Research · doi:10.1016/j.eplepsyres.2021.106593 · Cited by 4
Jaxybayeva, A., Nauryzbayeva, A., Khamzina, A., Takhanova, M., Abilhadirova, A., Rybalko, A., & Jamanbekova, K. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.639317 · Cited by 6
Paroxysmal Non‐Kinesigenic Dyskinesia: Utility of the Quantification of GLUT1 in Red Blood Cells
Soliani, L., Martorell, L., Yubero, D., Verges, C., Petit, V., & Ortigoza‐Escobar, J. D. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13391 · Cited by 4
Monogenetic epilepsies and how to approach them in 2022
Krey, I., Platzer, K., & Lemke, J. R. (2022) · Medizinische Genetik · doi:10.1515/medgen-2022-2143 · Cited by 6
Fasaludeen, A., McTague, A., Jose, M., Banerjee, M., Sundaram, S., Madhusoodanan, U. K., Radhakrishnan, A., & Menon, R. N. (2024) · Epilepsy Research · doi:10.1016/j.eplepsyres.2024.107341 · Cited by 4
Takeguchi, R., Akaba, Y., Kuroda, M., Tanaka, R., Tanaka, T., Itoh, M., & Takahashi, S. (2024) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2024.123063 · Cited by 4
Independent genetic strategies define the scope and limits of CDKL5 deficiency disorder reversal
Song, X., Xia, Z., Martinez, D., Xu, B., Spritzer, Z., Zhang, Y., Nugent, E., Ho, Y., Terzic, B., & Zhou, Z. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101926 · Cited by 8
Lolk, K., Dreier, J. W., Sun, Y., & Christensen, J. (2022) · Acta Neurologica Scandinavica · doi:10.1111/ane.13605 · Cited by 4
Genetic testing in adults with developmental and epileptic encephalopathy – what do we know?
Krey, I., Johannesen, K. M., Kohnen, O., & Lemke, J. R. (2022) · Medizinische Genetik · doi:10.1515/medgen-2022-2144 · Cited by 6
Toro-Perez, J. E., Healy, S. A., Sell, E., Bulusu, S., & Whiting, S. E. (2023) · Epileptic Disorders · doi:10.1002/epd2.20063 · Cited by 4
Balaji, A., Mohanlal, S., Pachat, D., Babu, S. S., Suresh Kumar, E. K., Mamukoya, N., & Das, S. (2023) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_314_23 · Cited by 6
Predictors of genetic diagnosis in individuals with developmental and epileptic encephalopathies
Benevides, M. L., de Moraes, H. T., Granados, D. M. M., Bonadia, L. C., Sauma, L., Montenegro, M. A., Guerreiro, M. M., Lopes‐Cendes, Í., & Coan, A. C. (2024) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2024.109762 · Cited by 4
Kanmaz, S., Yılmaz, S., Ölçülü, C. B., Toprak, D. E., İnce, T., Yılmaz, Ö., Ataş, Y., Şen, G., Şimşek, E., Serin, H. M., et al. (2024) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2024.05.018 · Cited by 4
Precision medicine in early-onset epilepsy: the KCNQ2 paradigm
Amadori, E., Brolatti, N., Scala, M., Marchese, F., Vari, M. S., Ramenghi, L. A., Madia, F., Minetti, C., & Striano, P. (2020) · Journal of Translational Genetics and Genomics · doi:10.20517/jtgg.2020.36 · Cited by 4
Kelada, L., Best, S., Pierce, K., Allen, M., Cobb, J. E., Berens, K., Goranitis, I., Palmer, E. E., Scheffer, I. E., & Howell, K. B. (2025) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2025.01.007 · Cited by 4
Tang, M., Teng, S., Kim, A. Y., Peng, Y., & Monani, U. R. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107047 · Cited by 2
Li, N., Yan, L., Peng, A., Fu, X., Qin, H., & Yao, K. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00260 · Cited by 7
Nonseizure Outcomes in Dravet Syndrome: Potential Impact of Pharmacotherapy
Swindler, A., Harper, A. J., Hendry, K., Strzelczyk, A., Reilly, C. J., & Brunklaus, A. (2025) · CNS Drugs · doi:10.1007/s40263-025-01212-5 · Cited by 6
Self-citationFasaludeen, A., Jose, M., Aswathi, U., Banerjee, M., Sundaram, S., Radhakrishnan, A., Urulangodi, M., Gupta, D. K., Nampoothiri, S., & Menon, R. N. (2025) · Clinical Genetics · doi:10.1111/cge.70061 · Cited by 4
Chen, Y., Zeng, C., Luo, C., Huang, B., Chen, S., Deng, W., Lan, S., & Li, C. (2025) · Seizure · doi:10.1016/j.seizure.2025.10.022 · Cited by 3
‘What's in a Name?’ Naming Genetically Determined Movement Disorders: Gap and Controversy
Marras, C., Albanese, A., Hallett, M., Klein, C., Lohmann, K., & Jinnah, H. A. (2025) · Movement Disorders · doi:10.1002/mds.70143 · Cited by 3
Engineering a human-based translational activator for targeted protein expression restoration
Sinnott, R. W., Solanki, A., Govind, A. P., Green, W. N., & Dickinson, B. C. (2026) · Nucleic Acids Research · doi:10.1093/nar/gkag113 · Cited by 3
Genetic-cellular epilepsy: Clues to diagnosing newborns with neonatal seizures
Panjan, M., Paro‐Panjan, D., & Šalamon, A. S. (2021) · Seizure · doi:10.1016/j.seizure.2021.08.013 · Cited by 4
The influence of genetics on epilepsy syndromes in infancy and childhood
Yozawitz, E. G., & Moshé, S. L. (2022) · Acta Epileptologica · doi:10.1186/s42494-022-00110-3 · Cited by 5
CDKL5 deficiency causes epileptic seizures independent of cellular mosaicism
Takahashi, S., Takeguchi, R., Tanaka, R., Fukuoka, M., Koike, T., Ohtani, H., Inoue, K., Fukuda, M., Kurahashi, H., Nakamura, K., et al. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120498 · Cited by 3
Peri‐ictal EEG in infants with PRRT2‐related self‐limited infantile epilepsy
Fearn, N. D., Macdonald‐Laurs, E., Moylan, L., & Howell, K. B. (2023) · Epileptic Disorders · doi:10.1002/epd2.20072 · Cited by 3
Socrates: A Novel N-Ethyl-N-nitrosourea-Induced Mouse Mutant with Audiogenic Epilepsy
Varlamova, E. G., Borisova, E. V., Evstratova, Y. A., Newman, A. G., Kuldaeva, V. P., Gavrish, M. S., Kondakova, E. V., Tarabykin, V. S., Babaev, A. A., & Turovsky, E. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317104 · Cited by 3
Familial KCNQ2 mutation: a psychiatric perspective
Iftimovici, A., Charmet, A., Desnous, B., Ory, A., Delorme, R., Coutton, C., Devillard, F., Milh, M., & Maruani, A. (2023) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000360 · Cited by 5
Kanmaz, S., Tekgül, H., Kayılıoğlu, H., Ataş, Y., Kart, P. Ö., Yıldız, N., Gümüş, H., Aydin, K., Kanmaz, S., Kayilioglu, H., et al. (2024) · Seizure · doi:10.1016/j.seizure.2024.09.021 · Cited by 3
Measuring the Burden of Epilepsy Hospitalizations in CDKL5 Deficiency Disorder
Junaid, M. A., Wong, K., Korolainen, M. A., Amin, S., Downs, J. A., & Leonard, H. (2024) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2024.11.010 · Cited by 3
Genetic Epilepsies With Onset in Infancy and Toddlerhood: A Prospective Single-Center Study in India
Basavanagowda, T., & Kamate, M. (2025) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2025.02.002 · Cited by 3
Blueprint for clinical N-of-1 strategies with off-label precision treatments in monogenic epilepsies
Defelippe, V. M., Brilstra, E. H., Otte, W. M., van Thiel, G. J. M. W., Cross, J. H., O'Callaghan, F. J., GIORGIS, V. D., Perucca, E., Braun, K. P. J., & Jansen, F. E. (2025) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-025-03750-z · Cited by 4
A case of Dravet syndrome with a novel SCN1A gross deletion involving the promoter region
Sakamoto, E. N., Shimada, S., Yamaguchi, T., Ishida, T., Imai, K., Eguchi, H., Okazaki, Y., & Arai, M. (2025) · Human Genome Variation · doi:10.1038/s41439-025-00320-4 · Cited by 3
Understanding lived experiences with KCNQ2 developmental and epileptic encephalopathy
Potashman, M. H., Rüdell, K., Abetz‐Webb, L., Suminski, N., Gold, A., Doma, R., Jarodia, K., Buckley, C., Ridley, M., Lerner, J. T., et al. (2025) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2025.110670 · Cited by 3
PRRT2 Related Epilepsies: A Gene Review
Massimino, C. R., Portale, L., Sapuppo, A., Pizzo, F., Sciuto, L., Romano, C., Salafia, S., & Falsaperla, R. (2021) · Journal of Pediatric Neurology · doi:10.1055/s-0041-1728683 · Cited by 3
Hernández, A. V. M., Caro‐Llopis, A., Rubio-Sanchez, P., Martínez, J. C., Vila, M. T., Monfort, S., & Martínez, F. (2022) · Journal of Child Neurology · doi:10.1177/08830738211072694 · Cited by 4
Telehealth for patients with rare epilepsies
Kramer, Z. J., Brandt, C., Havens, K. A., Pasupuleti, A., Gaillard, W. D., & Schreiber, J. M. (2022) · Therapeutic Advances in Rare Disease · doi:10.1177/26330040221076861 · Cited by 5
Howell, K. B., Butcher, S., Schneider, A., Russ-Hall, S. J., Muzariri, P. R., Kerr, R. S., Overmars, I., Hayman, M., Kornberg, A. J., Danchin, M. H., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000201438 · Cited by 4
Nakamura, S., Ito, Y., Hayakawa, H., Aoki, S., Yamagata, T., & Osaka, H. (2023) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2022.100954 · Cited by 3
Feria-Romero, I. A., Reyes-Cuayahuitl, A., Sosa-Maldonado, J., Montes-Aparicio, A. V., Mares, D. R., Pérez‐Pérez, D., Grijalva, I., & Orozco-Suárez, S. A. (2023) · Gene · doi:10.1016/j.gene.2023.147565 · Cited by 3
Broadening the scope of multigene panel analysis for adult epilepsy patients
Lee, S., Kang, M., So, K. H., Jang, R., Shin, Y. W., Jang, S., Yoon, J. G., Kim, S., Kim, M., Chu, K., et al. (2024) · Epilepsia Open · doi:10.1002/epi4.12993 · Cited by 2
Çelebi, H. B. G., Çetin, İ. D., Bolat, H., & Ünsel‐Bolat, G. (2024) · International Journal of Developmental Neuroscience · doi:10.1002/jdn.10360 · Cited by 3
Multicenter retrospective study of patients with PCDH19‐related epilepsy: The first Hungarian cohort
Kovacs, M., Fogarasi, A., Hegyi, M., Siegler, Z., Kelemen, A., Mellár, M., Orbók, A., Simon, G., Farkas, M. K., Bessenyei, M., et al. (2024) · Epileptic Disorders · doi:10.1002/epd2.20264 · Cited by 3
Mottolese, N., Coiffard, O., Ferraguto, C., Manolis, A., Ciani, E., & Pietropaolo, S. (2024) · Autism Research · doi:10.1002/aur.3226 · Cited by 6
Anesthetic considerations in Dravet syndrome
Macdonald‐Laurs, E., Corlette, S. J., Davidson, A. J., & Howell, K. B. (2022) · Pediatric Anesthesia · doi:10.1111/pan.14525 · Cited by 3
Feng, H., Qiao, F., Tan, J., Zhang, X., Hu, P., Shi, Y. S., & Xu, Z. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24196 · Cited by 2
Gene tests in adults with epilepsy and intellectual disability
Ottman, R., & Poduri, A. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0388-5 · Cited by 3
How gene discovery has transformed management of people with epilepsy
Scheffer, I. E. (2020) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2020.01.010 · Cited by 3
Advances in genotype-phenotype associations for CACNA1A-related epilepsies
Brunklaus, A. (2021) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2021.07.001 · Cited by 3
Self-citation
Metadata
- Authors
- Symonds, J. D., Zuberi, S. M., Stewart, K., McLellan, A., O‘Regan, M., MacLeod, S., Jollands, A., Joss, S., Kirkpatrick, M., Brunklaus, A., Pilz, D. T., Shetty, J., Dorris, L., Abu-Arafeh, I., Andrew, J., Brink, P., Callaghan, M., Cruden, J., Diver, L. A., Findlay, C., Gardiner, S., Grattan, R., Lang, B., MacDonnell, J., McKnight, J., Morrison, C. A., Nairn, L., Slean, M. M., Stephen, E., Webb, A., Vincent, A., & Wilson, M.
- Affiliations
- Royal Hospital for Children (GB)
- Queen Elizabeth University Hospital (GB)
- Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK
- NHS Tayside (GB)
- Department of Paediatrics, Forth Valley Royal Hospital, Larbert, UK
- Wishaw General Hospital (GB)
- Victoria Hospital (GB)
- University Hospital Crosshouse (GB)
- Forth Valley Royal Hospital (GB)
- John Radcliffe Hospital (GB)
- Borders General Hospital (GB)
- Dumfries and Galloway Royal Infirmary (GB)
- Royal Alexandra Hospital (GB)
- University of Glasgow (GB)
- Royal Aberdeen Children's Hospital (GB)
- Raigmore Hospital (GB)
- Corresponding author
- Zuberi, Sameer M
- ORCID
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-07-13
- Volume
- 142
- Issue
- 8
- Pages
- 2303-2318
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC6658850
- OpenAlex
- W2961503558
- Cited by
- 459
- References
- 81
- Citations by year
- 2026: 49 · 2025: 82 · 2024: 87 · 2023: 67 · 2022: 76 · 2021: 44 · 2020: 48 · 2019: 6
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Brain (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion, cc-by-nc)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion, cc-by-sa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- Epilepsy Research UK
- Dravet Syndrome UK
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Keywords
- childhood-onset epilepsy, genetic epilepsy, incidence, phenotypic spectrum, PRRT2, SCN1A, KCNQ2, KCNQ3, KCNA2, KCNA1, Kv1.3 potassium channel, Kv1.5, KC
- MeSH terms
- Child, Preschool, Epilepsy, Female, Humans, Infant, Infant, Newborn, Male, Phenotype, Prospective Studies, Scotland, Cohort Studies, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.